Stock Movers Ventyx Rises on Eli Lilly Deal; Mobileye to Buy Robot Maker; Strategy Shares Gain
Jan 7, 2026
Ventyx shares surged after Eli Lilly expressed interest in a $1 billion acquisition to enhance its immunology efforts. Mobileye is making waves with its $900 million deal to acquire Mentee Robotics, bolstering its robotics capabilities for self-driving cars. Meanwhile, Michael Saylor’s company sees rising stock prices as MSCI opts to retain digital asset treasury companies in its indexes. Tune in for insights into these major market moves and their implications!
AI Snips
Chapters
Transcript
Episode notes
Big Pharma Eyes Small Biotech
- Ventyx shares jumped after reports Eli Lilly is in advanced talks to buy the biotech for over $1 billion.
- Lilly seeks immunology assets to offset upcoming patent losses on some of its inflammatory drugs.
Auto Tech Moves Into Robotics
- Mobileye is acquiring Israeli startup Mentee Robotics in a $900 million cash-and-stock deal.
- The move expands robotics capability as automakers invest in humanoid robots for assembly and other tasks.
Indexes Pause On Crypto-Treasury Cuts
- Strategy's shares rose after MSCI decided to keep digital-asset treasury companies in indexes for now.
- MSCI will consult further, so index treatment could change in the future.